Financhill
Sell
39

ADCT Quote, Financials, Valuation and Earnings

Last price:
$3.51
Seasonality move :
40.45%
Day range:
$3.46 - $3.55
52-week range:
$1.05 - $4.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.40x
P/B ratio:
--
Volume:
549.1K
Avg. volume:
1.6M
1-year change:
65.57%
Market cap:
$434.8M
Revenue:
$70.8M
EPS (TTM):
-$1.45

Earnings Data

Next earnings date for ADCT
Apr 02
2026
Most recent earnings per share
-$0.30
Missed by $0.30
(Nov 10/2025)
Consensus Estimate
--
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADCT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2025 Q4 $18.3M -- -- -- --
11/10/2025 Q3 $16.8M $16.4M -$0.30 -- --
08/12/2025 Q2 $17.9M $18.8M -$0.50 -- --
05/05/2025 Q1 $17.7M $23M -$0.36 -- --
03/27/2025 Q4 $19M $16.9M -$0.29 -- --
11/07/2024 Q3 $18.5M $18.5M -$0.42 -- --
08/06/2024 Q2 $18.8M $17.4M -$0.38 -- --
05/06/2024 Q1 $18.1M $18.1M -$0.56 -- --
03/13/2024 Q4 $15.3M $16.8M -$1.03 -- --
11/07/2023 Q3 -- $14.5M -$0.57 -- --
08/08/2023 Q2 -- $19.3M -$0.60 -- --
05/09/2023 Q1 -- $19M -$0.73 -- --
02/28/2023 Q4 -- $69.8M -$0.29 -- --
11/08/2022 Q3 -- $76.3M -$0.65 -- --
08/09/2022 Q2 -- $17.3M -$0.84 -- --
05/09/2022 Q1 -- $46.5M -$0.22 -- --
03/03/2022 Q4 -- $17M -$0.45 -- --
11/02/2021 Q3 -- $13.1M -$0.93 -- --
08/03/2021 Q2 -- $3.8M -$0.95 -- --
05/06/2021 Q1 -- -- -$0.67 -- --
03/18/2021 Q4 -- -- -$0.73 -- --
11/12/2020 Q3 -- -- -$0.29 -- --
08/18/2020 Q2 -- -- -$2.01 -- --
03/31/2020 Q1 -- -- -$0.65 -- --
12/31/2019 Q4 -- -- -- -- --
09/30/2019 Q3 -- -- -- -- --
06/30/2019 Q2 -- -- -- -- --
03/31/2019 Q1 -- -- -- -- --
12/31/2018 Q4 -- -- -- -- --
09/30/2018 Q3 -- -- -- -- --
06/30/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -- --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -- --
06/30/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --

ADC Therapeutics SA Earnings Questions

  • How Much did ADC Therapeutics SA Generate in Revenue Last Quarter?

    ADC Therapeutics SA reported $16.4M worth of top line sales in its most recent quarter.

  • Did ADC Therapeutics SA Beat Earnings Last Quarter?

    ADC Therapeutics SA announced earnings per share of -$0.30 which represents a miss of analyst forecast a -- per share.

  • Is ADC Therapeutics SA Profitable?

    ADC Therapeutics SA reported $15.1M that represents $0.11 per share over the last quarter.

  • What is the Analyst Consensus for ADC Therapeutics SA EPS Next Year?

    ADC Therapeutics SA's earnings are forecast to decrease from -$1.62 per share to -$1.84 per share next year representing a decrease of -50.25%.

  • When is ADC Therapeutics SA's Earnings Date?

    ADC Therapeutics SA's next earnings date is April 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock